ALDH1A1 expression in benign and malignant prostate tissues

Abstract EN

Background : prostate cancer has few prognostic biomarkers, and differentiating between relapsing and non-relapsing Tumour can be challenging clinically.

aims : this study aims to investigate the hypothesis that aldh1a1 might be a potential biomarker for prostate tumors and could distinguish between aggressive Tumours requiring radical intervention and those that have a good prognosis.

it is thought to be a potential biomarker that can predict the clinical progression and prognosis of different kinds of Tumours.

however, its role in prostate cancer remains unclear.

materials and methods : aldh1a1 expression has been evaluated by immunohistochemistry using 96 prostate tissue samples including normal, adjacent normal and cancer tissues.

results : this study showed that aldh1a1 was expressed in glandular and stromal regions of both benign and malignant prostate tissues.

nuclear and cytoplasmic aldh1a1 was increased significantly in glandular regions of prostate cancer and was positively associated with increased tumor size.

however, stromal aldh1a1 staining was not associated with prostate cancer and other parameters such as primary Gleason grade and stage.

conclusion : this preliminary data suggests that aldh1a1 may have a role in cancer development and/or aggressiveness and warrants further investigation to understand its function and establish if it could be a potential diagnostic biomarker for prostate cancer.